← Back to all clusters

Cluster 292

8 diseases · 14 shared-gene connections
8 Diseases
8 Unique genes
0.227 Avg. similarity score
Complement pathway abnormality Most-connected disease (7 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Systemic lupus erythematosus related to C1QA Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
C1QA 4 / 8 C1q deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency, Systemic lupus erythematosus related to C1QA
C1QB 3 / 8 C1q deficiency, Complement pathway abnormality, Immunodeficiency due to an early component of complement deficiency
C1QC 3 / 8 C1q deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency
C1R 3 / 8 Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency, Periodontal ehlers-danlos syndrome
C1S 3 / 8 C1s deficiency, Complement pathway abnormality, Periodontal ehlers-danlos syndrome
C4A 3 / 8 C4a deficiency, Complement pathway abnormality, Immunodeficiency due to a classical component pathway complement deficiency
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Initial triggering of complement Reactome 8 / 17 706× 2.27e-24 3.34e-21 ✓ sig.
Regulation of Complement cascade Reactome 8 / 47 256× 2.94e-20 2.24e-17 ✓ sig.
Pertussis KEGG 8 / 78 154× 2.19e-18 1.27e-15 ✓ sig.
Complement and coagulation cascades KEGG 8 / 88 136× 6.00e-18 3.24e-15 ✓ sig.
Staphylococcus aureus infection KEGG 8 / 99 121× 1.60e-17 7.90e-15 ✓ sig.
Classical antibody-mediated complement activation Reactome 5 / 6 1,251× 1.61e-16 6.46e-14 ✓ sig.
Systemic lupus erythematosus KEGG 8 / 140 85.8× 2.79e-16 1.08e-13 ✓ sig.
Coronavirus disease - COVID-19 KEGG 8 / 238 50.5× 2.12e-14 5.65e-12 ✓ sig.
Alcoholic liver disease KEGG 6 / 144 62.6× 7.35e-11 8.97e-9 ✓ sig.
Activation of C3 and C5 Reactome 3 / 8 563× 1.08e-8 7.96e-7 ✓ sig.
Chagas disease KEGG 3 / 103 43.7× 3.33e-5 7.90e-4 ✓ sig.
Efferocytosis KEGG 3 / 157 28.7× 1.17e-4 2.14e-3 ✓ sig.
Prion disease KEGG 3 / 275 16.4× 6.11e-4 7.81e-3 ✓ sig.
Post-translational protein phosphorylation Reactome 2 / 108 27.8× 2.17e-3 2.02e-2 ✓ sig.
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Reactome 2 / 125 24.0× 2.89e-3 2.48e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
complement activation, classical pathway GO:0006958 8 / 37 505× 1.05e-22 2.45e-19 ✓ sig.
complement activation GO:0006956 7 / 35 467× 3.41e-19 4.84e-16 ✓ sig.
opsonization GO:0008228 5 / 18 649× 2.52e-14 1.62e-11 ✓ sig.
innate immune response GO:0045087 8 / 605 30.9× 1.15e-12 5.41e-10 ✓ sig.
activation of membrane attack complex GO:0001905 4 / 13 719× 9.84e-12 3.77e-9 ✓ sig.
immune system process GO:0002376 8 / 943 19.8× 4.09e-11 1.37e-8 ✓ sig.
positive regulation of apoptotic cell clearance GO:2000427 3 / 6 1,168× 1.03e-9 2.38e-7 ✓ sig.
synapse pruning GO:0098883 3 / 7 1,001× 1.80e-9 3.88e-7 ✓ sig.
complement activation, GZMK pathway GO:0160257 3 / 12 584× 1.13e-8 1.96e-6 ✓ sig.
killing of cells of another organism GO:0031640 4 / 104 89.8× 6.23e-8 8.54e-6 ✓ sig.
protein maturation GO:0051604 4 / 134 69.7× 1.73e-7 2.00e-5 ✓ sig.
complement activation, lectin pathway GO:0001867 2 / 13 359× 1.25e-5 6.46e-4 ✓ sig.
zymogen activation GO:0031638 2 / 32 146× 7.90e-5 2.60e-3 ✓ sig.
vertebrate eye-specific patterning GO:0150064 1 / 3 779× 1.28e-3 1.67e-2 ✓ sig.
detection of molecule of bacterial origin GO:0032490 1 / 3 779× 1.28e-3 1.67e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Complement pathway abnormality Immunodeficiency due to a classical component pathway complement deficiency 0.444 4 2.92e-14 3.41e-13 ✓ sig.
C1q deficiency Complement pathway abnormality 0.333 3 9.05e-11 8.46e-10 ✓ sig.
C1q deficiency Immunodeficiency due to a classical component pathway complement deficiency 0.333 2 1.50e-7 1.02e-6 ✓ sig.
Complement pathway abnormality Periodontal ehlers-danlos syndrome 0.222 2 2.33e-7 1.55e-6 ✓ sig.
C1s deficiency Periodontal ehlers-danlos syndrome 0.333 1 1.29e-4 3.27e-4 ✓ sig.
C1q deficiency Systemic lupus erythematosus related to C1QA 0.250 1 1.94e-4 4.41e-4 ✓ sig.
C1q deficiency Immunodeficiency due to an early component of complement deficiency 0.250 1 1.94e-4 4.41e-4 ✓ sig.
C4a deficiency Immunodeficiency due to a classical component pathway complement deficiency 0.200 1 2.58e-4 5.38e-4 ✓ sig.
Immunodeficiency due to a classical component pathway complement deficiency Systemic lupus erythematosus related to C1QA 0.200 1 2.58e-4 5.38e-4 ✓ sig.
Immunodeficiency due to a classical component pathway complement deficiency Periodontal ehlers-danlos syndrome 0.167 1 5.16e-4 9.13e-4 ✓ sig.
C1s deficiency Complement pathway abnormality 0.111 1 5.17e-4 9.13e-4 ✓ sig.
C4a deficiency Complement pathway abnormality 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Complement pathway abnormality Immunodeficiency due to an early component of complement deficiency 0.111 1 5.17e-4 9.13e-4 ✓ sig.
Complement pathway abnormality Systemic lupus erythematosus related to C1QA 0.111 1 5.17e-4 9.13e-4 ✓ sig.